✦ LIBER ✦

Costs associated with angiogenesis inhibitor therapies for metastatic renal cell carcinoma in clinical practice: Results from a medical chart review study

✍ Scribed by Choueiri, Toni K.; McDermott, David; Sheng Duh, Mei; Sarda, Sujata P.; Neary, Maureen P.; Oh, William K.

Book ID: 118503073
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 217 KB
Volume: 30
Category: Article
ISSN: 1078-1439
DOI: 10.1016/j.urolonc.2010.07.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Angiogenesis inhibitor therapies for met

Angiogenesis inhibitor therapies for metastatic renal cell carcinoma: effectiveness, safety and treatment patterns in clinical practice-based on medical chart review

✍ Toni K. Choueiri; Mei Sheng Duh; Jessica Clement; Ashley J. Brick; Miranda J. Ro 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB 👁 1 views

PCN50 COSTS OF TREATMENT WITH ANGIOGENES

PCN50 COSTS OF TREATMENT WITH ANGIOGENESIS INHIBITORS (AIS) IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC): RESULTS FROM A MEDICAL CHART REVIEW STUDY

✍ WK Oh; DF McDermott; MS Duh; L Antràs; K Chen; SP Sarda; A Luka; S Whittemore; P 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

PCN52 HEALTH CARE COSTS ASSOCIATED WITH

PCN52 HEALTH CARE COSTS ASSOCIATED WITH MULTIKINASE INHIBITORS (MKIS) FOR TREATMENT OF METASTATIC RENAL CELL CARCINOMA (MRCC) IN A CLINICAL PRACTICE SETTING IN ITALY

✍ C Paglino; C Porta; C Canipari; L Antràs; K Chen; S Whittemore; A Luka; P Ramamu 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

PCN2 SAFETY AND TREATMENT PATTERNS OF AN

PCN2 SAFETY AND TREATMENT PATTERNS OF ANGIOGENESIS INHIBITORS IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC) IN THE UNITED KINGDOM: PRELIMINARY RESULTS OF AN ONGOING CHARTS REVIEW STUDY

✍ R. Hawkins; J. Wagstaff; P. Nathan; S.P. Sarda; F. Vekeman; C. Korves; S. Dasgup 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB